Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Eiring

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancers|November 14, 2023
Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration. <i>Cancers</i> 2022, <i>14</i>, 5794Philippa K Brosch, Tessa Korsa, Danush Taban, et al.
Cancers|December 11, 2022
Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell MigrationPhilippa K Brosch, Tessa Korsa, Danush Taban, et al.
Angewandte Chemie (International Ed. in English)|October 4, 2021
Targetable Conformationally Restricted Cyanines Enable Photon-Count-Limited Applications*Patrick Eiring, Ryan McLaughlin, Siddharth S Matikonda, et al.
Communications Biology|June 26, 2021
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemiaAndoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Immunity|March 22, 2023
Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1Michaela Seeling, Matthias Pöhnl, Sibel Kara, et al.
Leukemia|March 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapyUmair Munawar, Johanna Thurner, Silvia Nerreter, et al.
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancers|November 14, 2023
Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration. <i>Cancers</i> 2022, <i>14</i>, 5794Philippa K Brosch, Tessa Korsa, Danush Taban, et al.
Cancers|December 11, 2022
Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell MigrationPhilippa K Brosch, Tessa Korsa, Danush Taban, et al.
Angewandte Chemie (International Ed. in English)|October 4, 2021
Targetable Conformationally Restricted Cyanines Enable Photon-Count-Limited Applications*Patrick Eiring, Ryan McLaughlin, Siddharth S Matikonda, et al.
Communications Biology|June 26, 2021
Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemiaAndoni Garitano-Trojaola, Ana Sancho, Ralph Götz, et al.
Immunity|March 22, 2023
Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1Michaela Seeling, Matthias Pöhnl, Sibel Kara, et al.
Leukemia|March 31, 2026
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapyUmair Munawar, Johanna Thurner, Silvia Nerreter, et al.
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Nature Communications|July 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatmentMarkus Haake, Beatrice Haack, Tina Schäfer, et al.
Pageof 2